Stock Earnings
URGN (UroGen Pharma Ltd) may reap gains as insiders became active recently
UroGen Pharma Ltd’s recent filing unveils that its Chief Medical Officer Schoenberg Mark unloaded Company’s shares for reported $11236.0 on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.